FCF YoY
+66.82%
OCF YoY
+55.06%
Capex YoY
+20.62%
FCF Conversion Δ
+5.7 pp
Free cash flow bridge for Edwards Lifesciences (EW) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Free cash flow: $436.40M
FCF bridge breakdown for Edwards Lifesciences (EW) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Free Cash Flow | $653.10M | — |
| Operating Cash Flow | $482.40M | +110.5% |
| Capital Expenditure | −$46.00M | -10.5% |
| Free Cash Flow | $1.09B | — |
- Prior Free Cash Flow$653.10M
- Operating Cash Flow$482.40M
- Capital Expenditure−$46.00M
- Free Cash Flow$1.09B
Identity check: drivers reconcile to ΔNI within $0.00 ✓
Want to see how cash flow is built up?Cash Flow Waterfall
Frequently asked questions
Data & methodology
Edwards Lifesciences (EW) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement